Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to $166.0 million.

  • Nutex Health's Cash & Current Investments rose 25397.69% to $166.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.0 million, marking a year-over-year increase of 25397.69%. This contributed to the annual value of $43.6 million for FY2024, which is 9807.69% up from last year.
  • Latest data reveals that Nutex Health reported Cash & Current Investments of $166.0 million as of Q3 2025, which was up 25397.69% from $96.7 million recorded in Q2 2025.
  • Nutex Health's 5-year Cash & Current Investments high stood at $166.0 million for Q3 2025, and its period low was $12.7 million during Q1 2022.
  • For the 5-year period, Nutex Health's Cash & Current Investments averaged around $44.9 million, with its median value being $34.3 million (2022).
  • In the last 5 years, Nutex Health's Cash & Current Investments skyrocketed by 13401415.84% in 2021 and then crashed by 3577.03% in 2023.
  • Over the past 5 years, Nutex Health's Cash & Current Investments (Quarter) stood at $36.1 million in 2021, then decreased by 5.16% to $34.3 million in 2022, then crashed by 35.77% to $22.0 million in 2023, then surged by 98.08% to $43.6 million in 2024, then skyrocketed by 281.01% to $166.0 million in 2025.
  • Its last three reported values are $166.0 million in Q3 2025, $96.7 million for Q2 2025, and $87.7 million during Q1 2025.